Arco Y. Jeng

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 494 citations

Molecular Pharmacology, Hypertension, Heart Failure +11

Mechanism of action of the phorbol ester tumor promoters: Specific receptors for lipophilic ligands

Peter M. Blumberg, Susan Jaken, Bernhard König et al. · Biochemical Pharmacology · 1984 · 205 citations

Signal Transduction, Biochemistry, Oncogenic Agent +6

Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action

Teruo Nakadate, Arco Y. Jeng, Peter M. Blumberg · Biochemical Pharmacology · 1988 · 191 citations

Signal Transduction, Signaling Pathway, Medicine +10

Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage

Anette Fiebeler, Jürg Nussberger, Erdenechimeg Shagdarsuren et al. · Circulation · 2005 · 179 citations · Full text

Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury

Margaret F. Prescott, Wilbur K. Sawyer, JEAN VON LINDEN‐REED et al. · Annals of the New York Academy of Sciences · 1999 · 142 citations